Bradyarrhythmia Clinical Trials
2 recruiting trials for Bradyarrhythmia. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Bradyarrhythmia clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Yonsei University (1), University Hospital of Ferrara (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Left bundle branch area pacing (procedure, 1 trial), followed by Right ventricular pacing, Cardiac pacing - Conventional RV pacing.
Track Bradyarrhythmia trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure...
PROTECT-SYNC study is a multicenter, randomized, controlled trial. A total of 7 medical centers across Republic of Korea will enroll 450 patients during 2 years of enrollment...
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
The goal of this observational study is to evaluate the clinical characteristics of patients undergoing permanent cardiac pacing and to compare procedural efficacy and safety of...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Bradyarrhythmia, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Bradyarrhythmia, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Bradyarrhythmia, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.